Evidence map›Paper›PMID 35122927›Full record

ArticleInternational journal of radiation oncology, biology, physics2022

Variable Effect of the COVID-19 Pandemic on Radiation Oncology Practices in the United States.

Daniel V Wakefield, Thomas Eichler, Emily Wilson, Liz Gardner, Casey Chollet-Lipscomb, David L Schwartz

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel V WakefieldTennessee Oncology, Nashville, Tennessee. Electronic address: daniel.wakefield23@gmail.com.
Thomas EichlerDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.
Emily WilsonAmerican Society for Radiation Oncology, Arlington, Virginia.
Liz GardnerAmerican Society for Radiation Oncology, Arlington, Virginia.
Casey Chollet-LipscombTennessee Oncology, Nashville, Tennessee.
David L SchwartzDepartment of Radiation Oncology, University of Tennessee Health Science Center, Memphis, Tennessee.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEarly in the pandemic, the American Society for Radiation Oncology surveyed physician leaders at radiation oncology practices in the United States to understand how the field was responding to the outbreak of COVID-19. METHODS AND MATERIALS: Surveys were repeated at multiple points during the pandemic, with a response rate of 43% in April 2020 and 23% in January 2021. To our knowledge, this is the only longitudinal COVID-19 practice survey in oncology in the United States.

resultsThe surveys indicate that patient access to essential radiation oncology services in the United States has been preserved throughout the COVID-19 pandemic. Safety protocols were universally adopted, telehealth was widely adopted and remains in use, and most clinics no longer deferred or postponed radiation treatments as of early 2021. Late-stage disease presentation, treatment interruptions, shortages of personal protective equipment, and vaccination barriers were reported significantly more at community-based practices than at academic practices, and rural practices appear to have faced increased obstacles.

conclusionsOur findings provide unique insights into the initial longitudinal effect of the COVID-19 pandemic on the delivery of radiation therapy in the United States. Downstream lessons in service adaptation and improvement can potentially be guided by formal concepts of resilience, which have been broadly embraced across the US economy.

Indexed as

COVID-19Radiation OncologyHumansPandemicsPersonal Protective EquipmentSARS-CoV-2United States

Identifiers

PMID35122927
PMCPMC8810273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.